TUXEDO-2 trial wraps up enrolment: Could Sahajanand Medical Technologies’ stent revolutionise diabetes care?
In a landmark achievement for cardiovascular medicine, Sahajanand Medical Technologies has announced the successful completion of patient enrolment for the TUXEDO-2 clinical trial in India. This pivotal study is set to explore the effectiveness and safety of the Supraflex Cruz Drug-Eluting Stent (DES) in diabetic patients suffering from multivessel coronary artery disease (CAD). The TUXEDO-2 […]